Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.12	50.16	64.41
Graham Fair Price	-72.73	23.20	85.08
PEG	553.84	-0.94	0.14
Price/Book	0.02	1.84	1.84
Price/Cash Flow	90.28	-35.62	-366.64
Prices/Earnings	1173.97	86.80	6.81
Price/Sales	-3.80	9.51	9.88
Price/FCF	90.28	-35.62	-366.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	18.82	0.44	0.37
Operating Margin	-9.56	0.09	0.09
ROA	-92.50	< 0.005	0.02
ROE	0.07	< 0.005	-92.15
ROIC	0.42	< 0.005	-98.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.05	75.38
Dividends QOQ	0.06	< 0.005	-86.92
EBIT QOQ	-0.78	-0.07	90.67
EPS QOQ	0.47	-0.92	94.84
FCF QOQ	-1.27	-9.16	-623.25
Revenue QOQ	-0.24	0.03	-89.42
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	84.34	96.45	14.36
Days Sales Outstanding (DSO)	46.03	41.40	-10.05
Inventory Turnover	1.07	0.93	-12.56
Debt/Capitalization	0.64	0.66	3.27
Quick Ratio	0.24	-0.37	53.13
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	69.07	67.22	-2.68
Cash	0.62	-17.67	2728.88
Capex	-5.36	-5.89	-9.96
Free Cash Flow	-0.35	-3.47	-901.87
Revenue	12.84	12.99	1.19
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.57	0.69	20.75
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.71	25.33	-20.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating